• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months

tetano

Editor, Senior Moderator
Front Immunol


. 2025 May 9:16:1596065.
doi: 10.3389/fimmu.2025.1596065. eCollection 2025. Reduced immune response to SARS-CoV-2 infection in the elderly after 6 months

Qin Luo[SUP] #[/SUP][SUP] 1 [/SUP], Qinqin Song[SUP] #[/SUP][SUP] 1 [/SUP], Yan Li[SUP] #[/SUP][SUP] 2 [/SUP], Kexin Zong[SUP] 3 [/SUP], Ti Liu[SUP] 2 [/SUP], Junming He[SUP] 4 [/SUP], Guoyong Mei[SUP] 1 [/SUP], Haijun Du[SUP] 1 [/SUP], Zhiqiang Xia[SUP] 1 [/SUP], Mi Liu[SUP] 1 [/SUP], Juan Song[SUP] 1 [/SUP], Chen Gao[SUP] 1 [/SUP], Dong Xia[SUP] 1 [/SUP], Guangyu Xue[SUP] 1 [/SUP], Wenyan Tian[SUP] 1 [/SUP], Yinli Qu[SUP] 1 [/SUP], Zengqiang Kou[SUP] 2 [/SUP], Zhongjun Dong[SUP] 5 6 [/SUP], Jun Han[SUP] 1 [/SUP]



Affiliations
Abstract

Objectives: To evaluate the immune persistence and cross-immune response of elderly individuals after Omicron BA.5 infections.
Method: The neutralizing antibodies against WT, BA.5, XBB.1 and EG.5 strains were analyzed. The T/B-cell subsets' responses were tested through intracellular cytokine staining and flow cytometry.
Results: The neutralizing antibodies titers against WT and BA.5 strain, remaining high level for at least 6 months, were higher than that of both XBB.1 and EG.5 variants. The neutralizing antibodies of WT, BA.5, XBB.1, and EG.5 strains in the elderly were slightly lower than those in middle-age. The memory B cells decreased rapidly in the elderly, and Tfh, Th17 cells of the elderly continued to increase for only 3 months, while Tfh and Th17 cells increased in the middle-aged for over 6 months. For the elderly, after peptide stimulation, unswitched/switched memory B cells decreased, while double negative B cells displayed higher proliferation. The proportions of both naïve and Temra cells in CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells declined, whereas those of Tcm and Tem cells elevated. In the meantime, both CD69[SUP]+[/SUP] and CD38[SUP]+[/SUP] T cells decreased, but the frequencies of PD-1[SUP]+[/SUP] and CTLA-4[SUP]+[/SUP] of CD4[SUP]+[/SUP] and CD8[SUP]+[/SUP] T cells showed an increasing trend. The proportions of PD-1[SUP]+[/SUP] and CTLA-4[SUP]+[/SUP] cells also increased in older people with long COVID symptoms at 3m post-infection.
Conclusions: Omicron BA.5 infection induced lower neutralizing antibodies against XBB.1 and EG.5 variant. The decrease of memory B cells, CD69[SUP]+[/SUP] and CD38[SUP]+[/SUP]T cells, as well as the increase of PD-1[SUP]+[/SUP], CTLA-4[SUP]+[/SUP] of CD4[SUP]+[/SUP]/CD8[SUP]+[/SUP]T cells and double negative B cells, indicate that sustained immune responses against BA.5 infection may wane more rapidly in elderly populations.

Keywords: T cell; adaptive immunity; elderly; neutralizing antibody; omicron BA.5.

 
Back
Top Bottom